Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis.

Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis.

Patients homozygous for the D90A mutation of the SOD1 gene (homD90A) demonstrate markedly slower progression of disease than those patients with sporadic ALS (SALS). PET studies have demonstrated a different cortical vulnerability in the two groups, reflected also in neurophysiological studies showi...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Turner, M, Hammers, A, Allsop, J, Al-Chalabi, A, Shaw, C, Brooks, D, Leigh, P, Andersen, P
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2007

Παρόμοια τεκμήρια

Cortical involvement in four cases of primary lateral sclerosis using [(11)C]-flumazenil PET.
ανά: Turner, M, κ.ά.
Έκδοση: (2007)

Cortical localisation of neuropsychological impairment in amyotrophic lateral sclerosis (ALS): An [C-11] Flumazenil PET study
ανά: Wicks, P, κ.ά.
Έκδοση: (2005)

Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an (11C)-flumazenil PET study.
ανά: Wicks, P, κ.ά.
Έκδοση: (2008)

Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.
ανά: Turner, M, κ.ά.
Έκδοση: (2002)

Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS.
ανά: Turner, M, κ.ά.
Έκδοση: (2005)

Genetics of sporadic amyotrophic lateral sclerosis.
ανά: Schymick, J, κ.ά.
Έκδοση: (2007)

Diffusion tensor imaging reveals white matter differences between sporadic and familial forms of amyotrophic lateral sclerosis
ανά: Stanton, B, κ.ά.
Έκδοση: (2008)

Diffusion tensor imaging in sporadic and familial (D90A SOD1) forms of amyotrophic lateral sclerosis.
ανά: Stanton, B, κ.ά.
Έκδοση: (2009)

Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: Studies with [11C]flumazenil PET
ανά: Turner, M, κ.ά.
Έκδοση: (2005)

Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET.
ανά: Turner, M, κ.ά.
Έκδοση: (2005)

Biomarkers in amyotrophic lateral sclerosis.
ανά: Turner, M, κ.ά.
Έκδοση: (2009)

Analysis of FGGY as a risk factor for sporadic amyotrophic lateral sclerosis.
ανά: Es, V, κ.ά.
Έκδοση: (2009)

Analysis of FGGY as a risk factor for sporadic amyotrophic lateral sclerosis.
ανά: Es, V, κ.ά.
Έκδοση: (2009)

A proposed staging system for amyotrophic lateral sclerosis.
ανά: Roche, J, κ.ά.
Έκδοση: (2012)

Neutrophil-to-lymphocyte ratio in sporadic amyotrophic lateral sclerosis
ανά: Qian-Qian Wei, κ.ά.
Έκδοση: (2022-01-01)

Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study.
ανά: Kew, J, κ.ά.
Έκδοση: (1993)

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials.
ανά: Balendra, R, κ.ά.
Έκδοση: (2015)

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials
ανά: Balendra, R, κ.ά.
Έκδοση: (2015)

Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis
ανά: Fogh, I, κ.ά.
Έκδοση: (2016)

Analysis of terms used for the diagnosis and classification of amyotrophic lateral sclerosis and motor neuron disease
ανά: Rutter-Locher, Z, κ.ά.
Έκδοση: (2016)

Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis.
ανά: Abrahams, S, κ.ά.
Έκδοση: (1997)

Diagnostic Circulating miRNAs in Sporadic Amyotrophic Lateral Sclerosis
ανά: A. Panio, κ.ά.
Έκδοση: (2022-05-01)

Amyotrophic lateral sclerosis
ανά: Leigh P Nigel, κ.ά.
Έκδοση: (2009-02-01)

Cortical 5-HT1A receptor binding in patients with homozygous D90A SOD1 vs sporadic ALS.
ανά: Turner, M, κ.ά.
Έκδοση: (2007)

Validation of an Amyotrophic Lateral Sclerosis Staging System Using Clinical Trial Data
ανά: Jones, A, κ.ά.
Έκδοση: (2013)

Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis.
ανά: Al-Chalabi, A, κ.ά.
Έκδοση: (2003)

REM sleep physiology and selective neuronal vulnerability in amyotrophic lateral sclerosis
ανά: Turner, M, κ.ά.
Έκδοση: (2020)

Genetic Analysis of Tryptophan Metabolism Genes in Sporadic Amyotrophic Lateral Sclerosis
ανά: Jennifer A. Fifita, κ.ά.
Έκδοση: (2021-06-01)

Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis.
ανά: Claudia Figueroa-Romero, κ.ά.
Έκδοση: (2012-01-01)

Targeted exon capture and sequencing in sporadic amyotrophic lateral sclerosis.
ανά: Julien Couthouis, κ.ά.
Έκδοση: (2014-10-01)

Novel Genetic Signatures Associated With Sporadic Amyotrophic Lateral Sclerosis
ανά: Robert Logan, κ.ά.
Έκδοση: (2022-03-01)

Cognitive Impairment in Chinese Patients with Sporadic Amyotrophic Lateral Sclerosis.
ανά: Bo Cui, κ.ά.
Έκδοση: (2015-01-01)

Amyotrophic lateral sclerosis and cerebellum
ανά: Renata Kabiljo, κ.ά.
Έκδοση: (2022-07-01)

Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis.
ανά: Jones, A, κ.ά.
Έκδοση: (2014)

Morphological abnormalities in mitochondria of the skin of patients with sporadic amyotrophic lateral sclerosis
ανά: Gabriel E. Rodríguez, κ.ά.
Έκδοση: (2012-01-01)

Young-onset amyotrophic lateral sclerosis: Historical and other observations
ανά: Turner, M, κ.ά.
Έκδοση: (2012)

Young-onset amyotrophic lateral sclerosis: historical and other observations.
ανά: Turner, M, κ.ά.
Έκδοση: (2012)

Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale.
ανά: Balendra, R, κ.ά.
Έκδοση: (2014)

Quantifying disease progression in amyotrophic lateral sclerosis.
ανά: Simon, N, κ.ά.
Έκδοση: (2014)

MRI Volumetric Analysis of the Thalamus and Hypothalamus in Amyotrophic Lateral Sclerosis
ανά: Shan Ye, κ.ά.
Έκδοση: (2022-01-01)